Life SciencesPharmaceuticalsTherapeutic AreaOncology/Hematology

Global Oncolytic Virus Therapy Market Size, Status and Forecast 2025

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $3,300 136 Pages QYResearch Group February, 2018 QYR15597330
Lowest Prices Guaranteed
Price from $3,300
Length 136 Pages
Publisher QYResearch Group
Published Date February, 2018
SKU QYR15597330

Global Oncolytic Virus Therapy Market Size, Status and Forecast 2025

This report studies the Oncolytic Virus Therapy market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Oncolytic Virus Therapy market by product type and applications/end industries.

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn¡¯t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. The total investment for Oncolytic Virus Therapy developing is around 84 M USD in 2017.

The major players in global Oncolytic Virus Therapy market include
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys

Geographically, this report is segmented into several key regions, with market size and R&D investment, market share and growth rate of Oncolytic Virus Therapy in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
Asia-Pacific

On the basis on the end users/applications, this report covers
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others


1 Oncolytic Virus Therapy Market Overview
1.1 Oncolytic Virus Therapy Product Overview
1.2 Oncolytic Virus Therapy Market by Pipeline
1.3 Oncolytic Virus Therapy Segment by Application
1.3.1 Global Oncolytic Virus Therapy R&D Investment and Growth Rate Comparison by Application (2013-2025)
1.3.2 Global Oncolytic Virus Therapy R&D Investment Market Share by Application in 2017
1.3.3 Prostate Cancer
1.3.4 Melanoma
1.3.5 Breast Cancer
1.3.6 Ovarian Cancer
1.4 Global Oncolytic Virus Therapy Market by Regions (2013-2018)
1.4.1 Global Oncolytic Virus Therapy Market Size and Growth Rate Comparison by Regions (2013-2025)
1.4.2 North America Oncolytic Virus Therapy Status and Prospect (2013-2025)
1.4.3 Europe Oncolytic Virus Therapy Status and Prospect (2013-2025)
1.4.4 Asia Pacific Oncolytic Virus Therapy Status and Prospect (2013-2025)
1.5 Global Oncolytic Virus Therapy Market Size (2013-2025)
2 Global Oncolytic Virus Therapy Market Competition by Manufacturers
2.1 Global Oncolytic Virus Therapy Pipeline of Key Players/Manufacturers
2.2 Global Oncolytic Virus Therapy R&D Investment and Share by Manufacturers (2016-2017)
2.3 Manufacturers Oncolytic Virus Therapy Headquarters, Established Date, Product Types
2.4 Oncolytic Virus Therapy Market Competitive Situation and Trends
2.4.1 Oncolytic Virus Therapy R&D Investment Concentration Rate
2.4.2 Oncolytic Virus Therapy R&D Investment Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 Global Oncolytic Virus Therapy R&D Investment by Regions (2013-2018)
3.1 Global Oncolytic Virus Therapy Developer Distribution by Regions
3.2 Global Oncolytic Virus Therapy R&D Investment and Market Share by Regions (2013-2018)
3.3 Global Oncolytic Virus Therapy R&D Investment and Growth Rate (2013-2018)
3.4 North America Oncolytic Virus Therapy R&D Investment and Growth Rate (2013-2018)
3.5 Europe Oncolytic Virus Therapy R&D Investment and Growth Rate (2013-2018)
3.6 Asia Pacific Oncolytic Virus Therapy R&D Investment and Growth Rate (2013-2018)
4 Global Oncolytic Virus Therapy Market Size by Regions (2013-2018)
4.1 Global Oncolytic Virus Therapy Consumption by Regions (2013-2018)
4.2 North America Oncolytic Virus Therapy Market Size (2013-2018)
4.3 Europe Oncolytic Virus Therapy Market Size (2013-2018)
4.4 Asia Pacific Oncolytic Virus Therapy Market Size (2013-2018)
5 Global Oncolytic Virus Therapy R&D Investment by Application
5.1 Global Oncolytic Virus Therapy Investment by Application (2013-2018)
5.2 Global Oncolytic Virus Therapy Market Size by Application (2013-2018)
6 Analysis of Oncolytic Virus Therapy Industry Key Manufacturers
6.1 Amgen
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 R&D Investment, Product and Stage
6.2 Oncolytics Biotech
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 R&D Investment, Product and Stage
6.3 Viralytics
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 R&D Investment, Product and Stage
6.4 Transgene SA
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 R&D Investment, Product and Stage
6.5 Oncolys BioPharma
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 R&D Investment, Product and Stage
6.6 Targovax
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 R&D Investment, Product and Stage
6.7 PsiOxus Therapeutics
6.7.1 Company Profile
6.7.2 Product Information
6.7.3 R&D Investment, Product and Stage
6.8 SillaJen Biotherapeutics
6.8.1 Company Profile
6.8.2 Product Information
6.8.3 R&D Investment, Product and Stage
6.9 Sorrento Therapeutics
6.9.1 Company Profile
6.9.2 Product Information
6.9.3 R&D Investment, Product and Stage
6.10 Lokon Pharma
6.10.1 Company Profile
6.10.2 Product Information
6.10.3 R&D Investment, Product and Stage
6.11 Genelux Corporation
6.11.1 Company Profile
6.11.2 Product Information
6.11.3 R&D Investment, Product and Stage
6.12 Vyriad
6.12.1 Company Profile
6.12.2 Product Information
6.12.3 R&D Investment, Product and Stage
6.13 TILT Biotherapeutics
6.13.1 Company Profile
6.13.2 Product Information
6.13.3 R&D Investment, Product and Stage
6.14 Cold Genesys
6.14.1 Company Profile
6.14.2 Product Information
6.14.3 R&D Investment, Product and Stage
7 New Drugs Manufacturing Cost Analysis
7.1 New Drugs R&D Cost Analysis
7.1.1 Clinical Phase Costs
7.1.2 Capitalized Costs
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.2.1 USA Labor Cost Analysis
7.2.2.2 Europe Labor Costs Analysis
7.2.2.3 Asia Labor Costs Analysis
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oncolytic Virus Therapy
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Oncolytic Virus Therapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Cancer Patients Analysis
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 Global Oncolytic Virus Therapy Market Forecast (2018-2025)
11.1 Global Oncolytic Virus Therapy R&D Investment and Market Size Forecast
11.1.1 Global Oncolytic Virus Therapy R&D Investment and Growth Rate Forecast (2018-2025)
11.1.2 Global Oncolytic Virus Therapy Market Size and Growth Rate Forecast (2018-2025)
11.2 Global Oncolytic Virus Therapy R&D Investment Forecast by Regions (2018-2025)
11.2.1 North America Oncolytic Virus Therapy R&D Investment Forecast (2018-2025)
11.2.2 Europe Oncolytic Virus Therapy R&D Investment Forecast (2018-2025)
11.2.3 Asia Pacific Oncolytic Virus Therapy R&D Investment Forecast (2018-2025)
11.3 Global Oncolytic Virus Therapy Market Size Forecast by Regions (2018-2025)
11.3.1 North America Oncolytic Virus Therapy Market Size Forecast (2018-2025)
11.3.2 Europe Oncolytic Virus Therapy Market Size Forecast (2018-2025)
11.3.3 Asia Pacific Oncolytic Virus Therapy Market Size Forecast (2018-2025)
11.4 Global Oncolytic Virus Therapy R&D Investment Forecast by Application (2018-2025)
11.5 Global Oncolytic Virus Therapy Market Size Forecast by Application (2018-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Product Picture of Oncolytic Virus Therapy
Table Oncolytic Virus Therapy Market by Pipeline
Table Global Oncolytic Virus Therapy R&D Investment (K USD) and Growth Rate Comparison by Application (2013-2025)
Figure Global Oncolytic Virus Therapy R&D Investment Market Share by Application in 2017
Figure Prostate Cancer Examples
Figure Melanoma Examples
Figure Breast Cancer Examples
Figure Ovarian Cancer Examples
Figure Global Oncolytic Virus Therapy Market Size (K USD) Comparison and Growth Rate by Regions (2013-2025)
Table Oncolytic Virus Therapy Market Size (K USD) Comparison by Regions (2013-2025)
Figure North America Oncolytic Virus Therapy Market Size (K USD) and Growth Rate (2013-2025)
Figure Europe Oncolytic Virus Therapy Revenue (M USD) and Growth Rate (2013-2025)
Figure Asia Pacific Oncolytic Virus Therapy Revenue (M USD) and Growth Rate (2013-2025)
Figure Global Oncolytic Virus Therapy Market Size (K USD) Status and Outlook (2013-2025)
Table Global Oncolytic Virus Therapy Pipeline of Key Players/Manufacturers
Table Global Oncolytic Virus Therapy R&D Investment (K USD) of Key Manufacturers (2016-2017)
Table Global Oncolytic Virus Therapy R&D Investment Share by Manufacturers (2016-2017)
Figure 2016 Oncolytic Virus Therapy R&D Investment Share by Manufacturers
Figure 2017 Oncolytic Virus Therapy R&D Investment Share by Manufacturers
Table Manufacturers Oncolytic Virus Therapy Headquarters and Established Date
Table Manufacturers Oncolytic Virus Therapy Product Category
Figure 2017 Oncolytic Virus Therapy R&D Investment Share by Manufacturers
Figure Oncolytic Virus Therapy R&D Investment Share of Top 3 Manufacturers
Figure Oncolytic Virus Therapy R&D Investment Share of Top 5 Manufacturers
Table Mergers & Acquisitions, Expansion
Table Global Oncolytic Virus Therapy Developer Distribution by Regions in 2017
Table Global Oncolytic Virus Therapy R&D Investment (K USD) by Regions (2013-2018)
Table Global Oncolytic Virus Therapy R&D Investment Market Share by Regions (2013-2018)
Figure Global Oncolytic Virus Therapy R&D Investment Market Share by Regions (2013-2018)
Figure 2017 Global Oncolytic Virus Therapy R&D Investment Market Share by Regions
Figure Global Oncolytic Virus Therapy R&D Investment (K USD) and Growth Rate (2013-2018)
Figure North America Oncolytic Virus Therapy R&D Investment (K USD) and Growth Rate (2013-2018)
Figure Europe Oncolytic Virus Therapy R&D Investment (K USD) and Growth Rate (2013-2018)
Figure Asia Pacific Oncolytic Virus Therapy R&D Investment (K USD) and Growth Rate (2013-2018)
Table Global Oncolytic Virus Therapy Market Size (K USD) by Regions (2013-2018)
Table Global Oncolytic Virus Therapy Consumption Market Share by Regions (2013-2018)
Figure Global Oncolytic Virus Therapy Consumption Market Share by Regions (2013-2018)
Figure 2017 Global Oncolytic Virus Therapy Consumption Market Share by Regions
Figure North America Oncolytic Virus Therapy Market Size (K USD) and Growth Rate (2013-2018)
Figure Europe Oncolytic Virus Therapy Market Size (K USD) and Growth Rate (2013-2018)
Figure Asia Pacific Oncolytic Virus Therapy Market Size (K USD) and Growth Rate (2013-2018)
Table Global Oncolytic Virus Therapy R&D Investment (K USD) by Application (2013-2018)
Table Global Oncolytic Virus Therapy R&D Investment Share by Application (2013-2018)
Figure R&D Investment Market Share of Oncolytic Virus Therapy by Application (2013-2018)
Figure 2013 R&D Investment Market Share of Oncolytic Virus Therapy by Application
Figure 2017 R&D Investment Market Share of Oncolytic Virus Therapy by Application
Table Global Oncolytic Virus Therapy Market Size (K USD) by Application (2013-2018)
Table Amgen Company Profile
Figure Oncolytic Virus Therapy Product Picture of Amgen
Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Amgen 2016-2017
Table Oncolytics Biotech Company Profile
Figure Oncolytic Virus Therapy Product Picture of Oncolytics Biotech
Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Oncolytics Biotech 2016-2017
Table Viralytics Company Profile
Figure Oncolytic Virus Therapy Product Picture of Viralytics
Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Viralytics 2016-2017
Table Transgene SA Company Profile
Figure Oncolytic Virus Therapy Product Picture of Transgene SA
Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Transgene SA 2016-2017
Table Oncolys BioPharma Company Profile
Figure Oncolytic Virus Therapy Product Picture of Oncolys BioPharma
Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Oncolys BioPharma 2016-2017
Table Targovax Company Profile
Figure Oncolytic Virus Therapy Product Picture of Targovax
Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Targovax 2016-2017
Table PsiOxus Therapeutics Company Profile
Figure Oncolytic Virus Therapy Product Picture of PsiOxus Therapeutics
Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of PsiOxus Therapeutics 2016-2017
Table SillaJen Biotherapeutics Company Profile
Figure Oncolytic Virus Therapy Product Picture of SillaJen Biotherapeutics
Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of SillaJen Biotherapeutics 2016-2017
Table Sorrento Therapeutics Company Profile
Figure Oncolytic Virus Therapy Product Picture of Sorrento Therapeutics
Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Sorrento Therapeutics 2016-2017
Table Lokon Pharma Company Profile
Figure Oncolytic Virus Therapy Product Picture of Lokon Pharma
Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Lokon Pharma 2016-2017
Table Genelux Corporation Company Profile
Figure Oncolytic Virus Therapy Product Picture of Genelux Corporation
Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Genelux Corporation 2016-2017
Table Vyriad Company Profile

$3,300
$6,600

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks